Gerardus Wilhelmus van Odijk
Chairman at Bavarian Nordic GmbH
Net worth: 637 905 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Paul Chaplin | M | 57 |
Bavarian Nordic GmbH
 Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | 25 years |
| Adam F. Cohen | M | 72 |
Centre for Human Drug Research
 Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | 37 years |
| Linda Wilding | M | 65 | 11 years | |
| Erik Gregers Hansen | M | 72 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | 14 years |
| Myles Lee | M | 70 | 7 years | |
| Anders Gersel Pedersen | M | 73 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | - |
| Frank Verwiel | M | 62 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | 8 years |
| Peter Henrik Kürstein-Jensen | M | 68 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | 12 years |
| Elizabeth Anderson | F | 66 |
Bavarian Nordic GmbH
Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The private company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | 7 years |
| Ton Logtenberg | M | 65 |
Hubrecht Organoid Technology Foundation
| 6 years |
| Jan Hendrik Egberts | M | 65 |
Centre for Human Drug Research
Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | 15 years |
| Alexander Berthold Hendrik Bakker | M | 57 | 14 years | |
| Jabine T. M. van der Meijs | M | 58 |
Centre for Human Drug Research
Centre for Human Drug Research BiotechnologyHealth Technology The Centre for Human Drug Research provides clinical drug research services. The private company is based in Leiden, Netherlands. Adam F. Cohen has been the CEO of the Dutch company since 1987. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Shelley Margetson | F | 53 | - | |
| Mark Throsby | M | 57 | 12 years | |
| Robert Koremans | M | 61 |
Teva Pharmaceuticals Europe BV
 Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | 1 years |
| John Peter | M | 80 | 10 years | |
| John Paul de Koning | M | 55 | 10 years | |
| Michael Gannon | M | - | 3 years | |
| Liam Michael FitzGerald | M | 58 | 23 years | |
| Lionel Carnot | M | 56 | 8 years | |
| Nancy Miller-Rich | F | 65 | 4 years | |
| Meron Mann | M | 72 |
Teva Pharmaceuticals Europe BV
Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | - |
| René Kuijten | M | 60 |
University of Utrecht
| 4 years |
| Amos Anatot | M | 70 |
Teva Pharmaceuticals Europe BV
Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | 19 years |
| Gary McGann | M | 74 | 10 years | |
| Hugh Friel | M | 79 | 5 years | |
| Ingrid M. A. de Graaf-de Swart | M | 55 |
University of Utrecht
| 6 years |
| Gabriele Schaeffner-Dallmann | M | - | - | |
| Setareh van Driel Shamsili | M | - | 4 years | |
| Adrianus Johannes Antonius Kas | M | - |
University of Utrecht
| 1 years |
| Ellen Broug | M | - | - | |
| Joost Lagendijk | M | 66 |
University of Utrecht
| 4 years |
| Gabriele Dallmann | M | 64 | 5 years | |
| Berend Scheffers | M | - |
University of Utrecht
| 4 years |
| Johannes Hermanus de Wit | M | 62 |
University of Utrecht
| 1 years |
| Adrianus Christianus Gerardus de Beer | M | 65 |
University of Utrecht
| 2 years |
| Joost Dröge | M | - |
University of Utrecht
| 5 years |
| Lilian Haagsman | F | - |
University of Utrecht
| 3 years |
| Keith Byrne | M | - | 6 years | |
| Eleanor Garvey | F | - | 6 years | |
| Sandy Eisen | M | 68 |
Teva Pharmaceuticals Europe BV
Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | 5 years |
| Marcel Zwaal | M | - |
Hubrecht Organoid Technology Foundation
| 1 years |
| Wolfgang Berthold | M | 77 | - | |
| John-Paul Schuirink | M | - |
University of Utrecht
| 4 years |
| Mark R.L. Krul | M | - | - | |
| Elaine Jones | M | 69 | - | |
| Leon Hooftman | M | - |
University of Utrecht
| 3 years |
| Jack Elands | M | - |
University of Utrecht
| 4 years |
| Hans Clevers | M | 67 |
Hubrecht Organoid Technology Foundation
| 6 years |
| Florent Gros | M | 56 | 6 years | |
| Roger Abravanel | M | 77 |
Teva Pharmaceuticals Europe BV
Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | - |
| J. F. M. Westendorp | M | 68 |
University of Utrecht
| 3 years |
| Marco Baptist Arie Keim | M | 62 |
University of Utrecht
| 3 years |
| Ruud van Anraat | M | 62 |
Teva Pharmaceuticals Europe BV
Teva Pharmaceuticals Europe BV MiscellaneousMiscellaneous Part of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Europe BV operates as an investment holding Dutch company and wholesales pharmaceutical goods and raw materials. The private company is based in Haarlem, Netherlands. | 3 years |
| Kees van der Leun | M | - |
University of Utrecht
| 4 years |
| Adrianus van Wijk | M | 68 |
University of Utrecht
| 3 years |
| Peter van Stiphout | M | - |
University of Utrecht
| 3 years |
| Bharat Tewarie | M | - |
University of Utrecht
| 4 years |
| Jason Avery | M | - | - | |
| Eimear Kenny | F | - | 8 years | |
| Tilman Hackeng | M | - |
University of Utrecht
| 1 years |
| Huub den Rooijen | M | - |
University of Utrecht
| 4 years |
| Jurgen Post | M | 67 |
University of Utrecht
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Netherlands | 47 | 73.44% |
| Ireland | 11 | 17.19% |
| Germany | 6 | 9.38% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gerardus Wilhelmus van Odijk
- Personal Network
